Close filters
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from peptides&elephants GmbH

Filter
No results were found for the filter!
Hint!
HHV5 UL44 HHV5 UL44
Pool of 106 peptides derived from a peptide scan (15mers with 11 aa overlap) through DNA polymerase processivity factor (Uni-Prot ID P16790) of Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5).
€230.00 *
Hint!
HIV-1 B Gag HIV-1 B Gag
Pool of 123 peptides derived from a peptide scan (15mers with 11 aa overlap) through Gag polyprotein (Uni-Prot ID P04591) of Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1).
€230.00 *
Hint!
M. tuberculosis esxA esaT6 M. tuberculosis esxA esaT6
Pool of 21 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6 (Uni-Prot ID: P9WNK7) of M. Tuberculosis - strain ATCC 25618 / H37Rv.
€172.50 *
Hint!
M. tuberculosis esxB CFP-10 M. tuberculosis esxB CFP-10
Pool of 23 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein (Uni-Prot ID: P9WNK5) - EsxB of M. Tuberculosis - strain ATCC 25618 / H37Rv.
€172.50 *
Hint!
RBD B.1.617.2 (Delta) SCoV2 (Spike Glycoprotein) RBD B.1.617.2 (Delta) SCoV2 (Spike Glycoprotein)
Pool of 53 peptides derived from a peptide scan (Peptide scan (15mers with 11 aa overlap)) through Receptor Binding Domain of Spike Glycoprotein.
€230.00 *
Hint!
M. tuberculosis Ag85B M. tuberculosis Ag85B
Pool of 79 peptides derived from a peptide scan (15mers with 11 aa overlap) through Diacylglycerol acyltransferase/mycolyltransferase Ag85B (Uni-Prot ID: P9WQP1 ) of Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
€201.25 *
Hint!
M. tuberculosis Alpha-crystallin M. tuberculosis Alpha-crystallin
Pool of 34 peptides derived from a peptide scan (15mers with 11 aa overlap) through Alpha-crystallin (Uni-Prot ID: P9WMK1 ) of M. Tuberculosis - strain ATCC 25618 / H37Rv .
€172.50 *
Hint!
Omicron full length B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron full length B.1.1.529 SCoV2 (Spike...
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) .
€805.00 *
Hint!
BA.4/BA.5 Omicron full length SCoV2 (Spike Glycoprotein) BA.4/BA.5 Omicron full length SCoV2 (Spike...
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant BA.4/BA.5 of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) .
€805.00 *
Hint!
Tos1p Tos1p
Pool of114 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tos1p (UniProt ID: A0A1D8PJA8).
€172.50 *
Hint!
Secreted beta-glucosidase SUN41 Secreted beta-glucosidase SUN41
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Secreted beta-glucosidase SUN41 (UniProt ID: Q59NP5).
€172.50 *
Hint!
Secreted protein RBT4 Secreted protein RBT4
Pool of 87 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Secreted protein RBT4 (UniProt ID: Q5AB48).
€172.50 *
Transaldolase Transaldolase
Pool of 78 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Transaldolase (UniProt ID: Q5A017).
€172.50 *
Hint!
M. tuberculosis hspX M. tuberculosis hspX
Pool of 34 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Heat shock protein HSPX (Alpha-crystallin homolog) (UniProt ID: G0TM25).
€172.50 *
Hint!
Interleukin-17A human Interleukin-17A human
Pool of 36 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Interleukin-17A human (UniProt ID: Q16552).
€172.50 *
HBV Protein P Peptide Pool HBV Protein P Peptide Pool
Pool of 209 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein P (UniProt ID: Q9WRL0) of Hepatitis B virus (HBV)
€230.00 *
Hint!
M. tuberculosis esxH (TB10.4) M. tuberculosis esxH (TB10.4)
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein (Swiss-Prot ID: P9WNK3) - EsxH of M. Tuberculosis - strain ATCC 25618 / H37Rv.
€172.50 *
HHV1 Envelope Glycoprotein D HHV1 Envelope Glycoprotein D
Pool of 96 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein D (UniProt ID: P57083) of Human herpesvirus 1 (strain Patton) (HHV-1) (Human herpes simplex virus 1)
€172.50 *
HUMAN (ENO1) Peptide Pool HUMAN (ENO1) Peptide Pool
Pool of 106 peptides derived from a peptide scan (15mers with 11 aa overlap) through Enolase 1, (Alpha), isoform CRA_a (UniProt ID: A0A024R4F1) of Homo sapiens (Human) for T cell assays.
€172.50 *
f22 Peptide Pool f22 Peptide Pool
Pool of 107 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Enolase (UniProt ID: Q96X30) of Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus)
€172.50 *
crf1 Peptide Pool crf1 Peptide Pool
Pool of 96 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Probable glycosidase crf1 (UniProt ID: Q8J0P4) of Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus...
€172.50 *
Hyphally regulated cell wall protein 1 Hyphally regulated cell wall protein 1
Pool of227 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Hyphally regulated cell wall protein 1 (UniProt ID: Q5AL03).
€172.50 *
Candidapepsin-5 Candidapepsin-5
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Candidapepsin-5 (UniProt ID: P43094).
€172.50 *
Hint!
pH-regulated antigen PRA1 pH-regulated antigen PRA1
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through pH-regulated antigen PRA1 (UniProt ID: P87020).
€172.50 *
Elongation factor 2 Elongation factor 2
Pool of 208 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Elongation factor 2 (UniProt ID: Q5A0M4).
€218.50 *
Hint!
Glyceraldehyde-3-phosphate dehydrogenase Glyceraldehyde-3-phosphate dehydrogenase
Pool of 81 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Glyceraldehyde-3-phosphate dehydrogenase (UniProt ID: Q5A017).
€172.50 *
Hint!
Phosphoglycerate mutase Phosphoglycerate mutase
Pool of 60 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Phosphoglycerate mutase (UniProt ID: P82612).
€172.50 *
Candida (MP65) Candida (MP65)
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Mannoprotein MP65 (UniProt ID: Q9HEP1) of Candida albicans (Yeast) for T cell assays (e.g. ELISPOT)
€172.50 *
Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein) Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020.
€230.00 *
HHV6 (U90) Peptide Pool HHV6 (U90) Peptide Pool
Pool of 267 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein U90 (UniProt ID: Q77PU6) of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation).
€258.75 *
RSVA Peptide Pool RSVA Peptide Pool
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Major surface glycoprotein G (UniProt ID: P03423) of Human respiratory syncytial virus A (strain A2)
€172.50 *
Op4p Op4p
Pool of 99 peptides derived from a peptide scan (15mers with 11 aa overlap) through Op4p (uniprot A0A1D8PFJ9).
€172.50 *
pH-responsive protein 1 pH-responsive protein 1
Pool of 135 peptides derived from a peptide scan (15mers with 11 aa overlap) through pH-responsive protein 1 (uniprot P43076).
€172.50 *
Mesothelin 290-625 Mesothelin 290-625
Pool of 82 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein Mesothelin Human (UniProt ID: Q13421).
€172.50 *
BKV VP1 BKV VP1
Pool of 88 peptides derived from a peptide scan (15mers with 11 aa overlap) through Major capsid protein VP1 (UniProt ID: P14996) from BK polyomavirus (human).
€218.50 *
HPV16 E7 HPV16 E7
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E7 (Swiss-Prot ID: P03129) of Human papillomavirus.
€172.50 *
HPV16 E6 HPV16 E6
Pool of 37 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E6 (Swiss-Prot ID: P03126) of Human papillomavirus.
€172.50 *
HPV16 (L1) HPV16 (L1)
Pool of 124 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot ID: Q9WLQ6) of Human papillomavirus - type 16
€291.00 *
HPV16 (L2) HPV16 (L2)
Pool of 116 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot ID: P03107) of Human papillomavirus - type 16.
€291.00 *
HPV18 (L2) HPV18 (L2)
Pool of 113 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot ID: P06793) of Human papillomavirus.
€291.00 *
HPV18 (L1) HPV18 (L1)
Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot ID: P06794) of Human papillomavirus - type 18.
€291.00 *
HCMVA (IE1) Peptide Pool HCMVA (IE1) Peptide Pool
Pool of 120 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 55 kDa immediate-early protein 1 (IE-1) (UniProt ID: P13202) of Human cytomegalovirus (HHV-5) frequently used as positive control
€218.50 *
p53 (Y220C)
From €57.50 *
Details
Delta Variant B.1.617.2 SCoV2 wt (Spike Glycoprotein) Delta Variant B.1.617.2 SCoV2 wt (Spike...
This pool consists of 27 peptides of the spike protein and represent the wildtype peptides to the mutations of the delta variant of SARS-CoV-2 (B.1.617.2) and is therefore recommended as a reference.
€230.00 *
Omicron Variant B.1.1.529 SCoV2 wt (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 wt (Spike...
This pool consists of 82 peptides of the spike protein and represent the wildtype peptides to the mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529) and is therefore recommended as a reference.
€230.00 *
Hint!
Omicron Variant B.1.1.529 SCoV2 (Spike Glycoprotein) Omicron Variant B.1.1.529 SCoV2 (Spike...
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2 which is prevalent in south africa.
€230.00 *
Trp2 180-188
This peptide is derived from tyrosinase-related protein 2 (TRP-2) residues 180-188. TRP-2 peptide, also named L-dopachrome tautomerase, H-2KB or DCT, belongs to the melanocyte differentiation antigens and has been implicated as a target...
From €57.50 *
Details
[Phe17] - Apelin
Apelin has been found to be expressed in the spinal cord and the human brain and when performing immunohistochemistry it was observed that apelin-17 is significantly expressed in the human heart, brain, lungs and endothelial cells.
From €115.00 *
Details
SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01)
RLQSLQTYV is an antigen-specific SARS-CoV-2 peptide
From €92.00 *
Details
[beta]-Casomorphin (1-7), bovine
#
From €57.50 *
Details
Influenza A virus HA 306-318 (DRB1*01:01)
Antigen Peptide Influenza PKYVKQNTLKLAT for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays
From €92.00 *
Details
Human PRAME 254-262 (HLA-A24)
#
From €57.50 *
Details
HEL 11-25
#
From €115.00 *
Details
ACTH (1-39) (human)
ACTH (1-39), human is a synthetic peptide corresponding to the first 39 amino acids of human ACTH/adrenocorticotropin which is the major regulator of adrenal cortex function. ACTH stimulates the synthesis of steroidal hormones.
From €241.50 *
Details
ACTH (18-39) (human)
Adrenocorticotropic hormone (ACTH) (18-39) is a C-terminal peptide fragment of ACTH, a peptide hormone found in the brain that is involved in the biological stress response. ACTH is produced in the anterior pituitary gland upon...
From €172.50 *
Details
Lambda Variant C.37 SCoV2 (Spike Glycoprotein) Lambda Variant C.37 SCoV2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the lambda variant C.37 of SARS-CoV-2 which emerged in Peru in August 2020.
€230.00 *
Iota Variant B.1.526 SCoV2 (Spike Glycoprotein) Iota Variant B.1.526 SCoV2 (Spike Glycoprotein)
This peptide pool with 21 peptides covers all mutations in the Spike Glycoprotein derived from the iota variant B.1.526 of SARS-CoV-2 which emerged in the US in November 2020.
€230.00 *
Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Beta Variant B.1.351 SCoV2 (Spike Glycoprotein)
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta variant B.1.351 of SARS-CoV-2 which emerged in South Africa in December 2020 and reduces the effectiveness of some vaccines.
€230.00 *
Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and...
€230.00 *
Hint!
Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein) Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others.
€230.00 *
Gamma Variant P.1 SCoV2 (Spike Glycoprotein) Gamma Variant P.1 SCoV2 (Spike Glycoprotein)
This peptide pool with 36 peptides covers all mutations in the Spike Glycoprotein derived from the gamma variant P.1 of SARS-CoV-2 which emerged in Brazil in late 2020 and has similar mutations to the beta variant B.1.351.
€230.00 *
RSV Sub Peptide Pool (>95% HPLC) RSV Sub Peptide Pool (>95% HPLC)
This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Respiratory Syncytial Virus (RSV).
€63.25 *
CMV Sub Peptide Pool (>95% HPLC) CMV Sub Peptide Pool (>95% HPLC)
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).
€63.25 *
Proinsulin 90-104
This is a Proinsulin-derived peptide of GIVEQCCTSICSLYQ sequence covering 90-104 and DRB1*04:01 molecule.
From €115.00 *
Details
HBV Sub Peptide Pool (>95% HPLC) HBV Sub Peptide Pool (>95% HPLC)
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis B virus (HBV).
€63.25 *
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
SSCSSCPLTK is a linear mutated peptidic epitope (epitope ID60930) studied as part of Latent membrane protein 2 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays...
From €57.50 *
Details
RSV Fusion protein 540-548 (HLA-A*02:01)
#
From €57.50 *
Details
HIV Env 586-593 (HLA-B*08:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed Env-derived peptide of YLKDQQLL sequence covering 586-593 and...
From €57.50 *
Details
HIV env 816-825 (HLA-A*02:01)
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341 chronic, HIV-infected subjects, divided into controllers and non-controllers, were tested for EliSpot responses to 257 optimally...
From €57.50 *
Details
LCMV envelope gp 10-18 (HLA-A*02:01)
ALPHIIDEV is a linear peptidic epitope (epitope ID2814) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell...
From €57.50 *
Details
gp100 170-178 (HLA-A*24:02)
#
From €57.50 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D
EBV EBNA1-derived peptide of HPVGDADYFEY covering 407-417 and B*35:08 molecule. HPVGDADYFEY is a linear peptidic epitope (epitope ID 24525) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A
EBNA1-derived peptide of HPVAEADYFEY covering 407-417 and B*35:08 molecule. HPVAEADYFEY is a linear peptidic epitope (epitope ID 227777) studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus)....
From €92.00 *
Details
MBP (63–81)
#
From €149.50 *
Details
MOG 94 - 110, human
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €195.50 *
Details
MOG 40-55
Myelin oligodendrocyte glycoprotein (MOG) 40-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MOG 40-54
Myelin oligodendrocyte glycoprotein (MOG) 40-54, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
MBP (54-72) human
MBP (54-72) human - SHHAARTTHYGSLPQKSQR represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €195.50 *
Details
MOG 97-108
Myelin oligodendrocyte glycoprotein (MOG)97 - 108, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
FLAG
This epitope tag is a short hydrophilic, highly charged peptide. It is the most widely used epitope tag employed in structural and functional studies of proteins.
From €92.00 *
Details
RSV MP 229-237 (HLA-A*01:01)
#
From €57.50 *
Details
gp100 17-25 (HLA-A*03:01)
#
From €57.50 *
Details
Theta Variant P.3 SCoV2 (Spike Glycoprotein) Theta Variant P.3 SCoV2 (Spike Glycoprotein)
This peptide pool with 30 peptides covers all mutations in the Spike Glycoprotein derived from the theta variant P.3 of SARS-CoV-2 which emerged in the Philippines in January 2021.
€230.00 *
Zeta Variant P.2 SCoV2 (Spike Glycoprotein) Zeta Variant P.2 SCoV2 (Spike Glycoprotein)
This peptide pool with 12 peptides covers all mutations in the Spike Glycoprotein derived from the zeta variant P.2 of SARS-CoV-2 which emerged in Brazil in April 2020.
€230.00 *
Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike...
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2 which emerged in the US in March 2020.
€230.00 *
Eta Variant B.1.525 SCoV2 (Spike Glycoprotein) Eta Variant B.1.525 SCoV2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020.
€230.00 *
HA-1 137-145 His139 (HLA-A*02:01)
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VLHDDLLEA is a linear peptidic epitope (epitope ID136896)...
From €57.50 *
Details
EBV (GP350/GP340) Peptide Pool EBV (GP350/GP340) Peptide Pool
Pool of 224 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein GP350/GP340 (UniProt ID: P03200) of Epstein-Barr virus (HHV4)
€218.50 *
Survivin 5-14 (HLA-A*02:01)
Single peptide (TLPPAWQPFL) for stimulation of human Survivin (5-14)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
From €57.50 *
Details
HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune...
From €57.50 *
Details
WT1 126-134 (HLA-A*02:01)
RMFPNAPYL is a linear peptidic epitope (epitope ID54882) studied as part of Wilms tumor protein from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays WT-1 126-134...
From €57.50 *
Details
CD20 188-196 (HLA-A*02:01)
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide...
From €57.50 *
Details
Pr1 169-177 (HLA-A*02:01)
Antigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase 3-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. PR1 (VLQELNVTV) is a human...
From €57.50 *
Details
NY-ESO-1 157-165 (HLA-A*02:01)
NY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for stimulation of human NY-ESO-1-specific CD8+ T-cells SLLMWITQV is a linear peptidic epitope (epitope ID59283) studied as part of...
From €57.50 *
Details
WT1 235–243 mutant (HLA-A*24:02) 236Y
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a tumour suppressor gene associated with the development of Wilms' Tumour, from which it was named. Mutations in exon 7 and 9 of WT1...
From €57.50 *
Details
Mesothelin 20-28 (HLA-A*02:01)
This peptide is a MHC monomer of biotinylated peptide composed Mesothelin-derived peptide of SLLFLLFSL sequence and A*02:01 molecule. The pMHC monomer recognizes human CD8 T cells and can be used in the MHC tetramer analysis of...
From €57.50 *
Details
WT1 317–327 (HLA-A*01:01)
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a tumour suppressor gene associated with the development of Wilms' Tumour, from which it was named. Mutations in exon 7 and 9 of WT1...
From €57.50 *
Details
Insulin B 10-18 (HLA-A*02:01)
HLVEALYLV is a linear peptidic epitope (epitope ID100920) studied as part of Insulin (UniProt:P01308) from Homo sapiens (human), Insulin (UniProt:A6XGL2) from Homo sapiens (human) and Insulin, isoform 2 from Homo sapiens (human). This...
From €57.50 *
Details
OVA-Peptid (323-339) (H-2Kb)
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb. Ovalbumin peptide SIINFEKL (H-2 Kb) for stimulation of T cells. Single peptide (SIINFEKL) for...
From €92.00 *
Details
Hint!
HUMAN (Actin) Peptide Pool HUMAN (Actin) Peptide Pool
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Actin, alpha skeletal muscle (UniProt ID: P68133) of Homo sapiens (Human) for T cell assays frequently used as negative control
€172.50 *
Hint!
HCMV pp65 495-503 (HLA-A*02:01)
NLVPMVATV is a linear peptidic epitope (epitope ID44920) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus) and Unidentified protein from Unidentified. This epitope has been studied for immune...
From €57.50 *
Details
CEF (advanced) Peptide Pool (>95% HPLC) CEF (advanced) Peptide Pool (>95% HPLC)
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalovirus, Epstein- Barr virus and Influenza virus
€92.00 *
Hint!
MOG 35-55
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is...
From €115.00 *
Details
Hint!
HCMVA (pp65) Peptide Pool HCMVA (pp65) Peptide Pool
Control Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5) frequently used as positive control.
€178.25 *
Hint!
SARS-CoV-2 (Spike Glycoprotein) SARS-CoV-2 (Spike Glycoprotein)
Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory...
€575.00 *
EBV EBNA 3B 399-408 (HLA-A*11:01)
Antigen Peptide EBV EBNA3B 399-408 (HLA-A*11:01) AVFDRKSDAK for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
From €57.50 *
Details
EBV (EBNA-3b) Peptide Pool EBV (EBNA-3b) Peptide Pool
Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Epstein-Barr nuclear antigen 4 (EBNA3b) (UniProt ID: Q1HVG4) of Epstein-Barr virus (HHV4) for T cell assays.
€218.50 *
Influenza A (H1N1) HA Influenza A (H1N1) HA
Pool of 139 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Hemagglutinin (UniProt ID: C3W5S1) of Influenza A virus (strain swl A/California/04/2009 H1N1)
€230.00 *
MBP (1-11) human
MBP (1-11) human - ASQKRPSQRHG represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
From €57.50 *
Details
Influenza A NP 366-374 (H-2 Db)
This peptide is a tetramer of biotinylated peptide with streptavidin mainly composed of Influenza-derived peptide of ASNENMETM sequence covering 366-374 and H-2Db molecule. The pMHC tetramer recognizes mouse CD8 T cells, and can be used...
From €57.50 *
Details
HHV8 (K8.1) Peptide Pool HHV8 (K8.1) Peptide Pool
Pool of 55 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Glycoprotein gp35/37 (UniProt ID: O36551) of Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus) for T cell assays (antigen...
€201.25 *
LLO 216–227 (H2-Kd)
#
From €92.00 *
Details
LLO 189-200 (H2-Kd )
#
From €92.00 *
Details
p60 449–457 (H-2Kd)
#
From €57.50 *
Details
p60 476 - 484 (H-2Kd)
#
From €57.50 *
Details
P60 217-225 (H-2Kd)
#
From €57.50 *
Details
PRAME 242-251 (HLA-A*3)
#
From €57.50 *
Details
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
#
From €57.50 *
Details
HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G
#
From €57.50 *
Details
SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_3 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF6 prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF3a prot_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 ORF3a prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 226-234 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 1192–1200 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 978–986 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 958–966 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 691–699 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV-2 Surface GP A2 424–433 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane...
From €92.00 *
Details
SARS-CoV SSp-1 A2 (HLA-A*02:01)
The sequence is related to the HLA-A*0201-restricted coronavirus SARS-CoV spike protein peptide SSp-1. It was demonstrated that SARS-CoV protein-derived peptide-1 (SSp-1 RLNEVAKNL) induces peptide-specific CTLs both in vivo (transgenic...
From €92.00 *
Details
DEAD box RNA helicase 355–363 (HLA-C*05:01)
#
From €57.50 *
Details
Rev 67-75 mutant (HLA-C*05:01) 75L
#
From €57.50 *
Details
GAD65 113-132 (DRB1*04:01)
#
From €195.50 *
Details
GAD65 274-286 (DRB1*04:01)
#
From €149.50 *
Details
GAD65 555-567 (DRB1*04:01)
#
From €149.50 *
Details
fn20 env 122-141
#
From €195.50 *
Details
SNTB2 351-360
VTEKDLLLY is a linear peptidic epitope studied as part of Beta-2-syntrophin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays.
From €57.50 *
Details
HPV E6 31-38
HDIILECV is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in T cell assays.
From €57.50 *
Details
HPV E7 88-97 (HLA-A*11)
GIVCPICSQK is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HPV E6 133–142
HNIRGRWTGR is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in T cell assays.
From €57.50 *
Details
IE62 593-601 (HLA-A*02:01)
ALWALPHAA is a linear peptidic epitope studied as part of Major viral transcription factor ICP4 homolog from Human herpesvirus 3 (Varicella-zoster virus). This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
LCMV GP 118-125
ISHNFCNL is a linear peptidic epitope studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC...
From €57.50 *
Details
LCMV NP 205-212
YTVKYPNL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus, Nucleoprotein from Guanarito mammarenavirus, Nucleoprotein from Machupo mammarenavirus and Argentinian...
From €57.50 *
Details
LCMV NP 201-215
LGLLYTVKYPNLNDL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.
From €115.00 *
Details
LCMV NP 309-328
SGEGWPYIACRTSIVGRAWE is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays and B cell assays.
From €195.50 *
Details
TRP1 113-126 Mouse Tyrp2/gp75
CRPGWRGAACNQKI is a linear peptide tested in T cell assays and MHC ligand assay.
From €115.00 *
Details
EBV EBNA-1 72-80 (HLA-B*35:01)
RPQKRPSCI is a linear peptidic epitope studied as part of Epstein-Barr nuclear antigen 1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays.
From €57.50 *
Details
HCV NS3 1267-1275
LGFGAYMSK is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been tested in T cell assays and MHC ligand assays.
From €57.50 *
Details
HDV 46-54
DENPWLGNI is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus, this epitope has been tested in T cell assays and MHC ligand assays.